CA
CRL icon

Clearstead Advisors’s Charles River Laboratories CRL Stock Holding History

Clearstead Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.2K Buy
142
+120
+545% +$21.4K ﹤0.01% 1640
2026
Q1 		$3.79K Buy
22
+12
+120% +$2.23K ﹤0.01% 1778
2025
Q4 		$2K Sell
10
-36
-78% -$6.53K ﹤0.01% 2142
2025
Q3 		$7.2K Buy
46
+25
+119% +$3.97K ﹤0.01% 2033
2025
Q2 		$3.19K Sell
21
-77
-79% -$10.3K ﹤0.01% 2227
2025
Q1 		$14.8K Sell
98
-1,023
-91% -$172K ﹤0.01% 1500
2024
Q4 		$207K Sell
1,121
-13
-1% -$2.5K ﹤0.01% 845
2024
Q3 		$223K Sell
1,134
-47
-4% -$9.77K ﹤0.01% 823
2024
Q2 		$244K Buy
1,181
+1,062
+892% +$241K ﹤0.01% 751
2024
Q1 		$27.2K Buy
119
+9
+8% +$2.15K ﹤0.01% 891
2023
Q4 		$26K Buy
110
+79
+255% +$15.5K ﹤0.01% 894
2023
Q3 		$6.08K Buy
31
+21
+210% +$4.31K ﹤0.01% 1057
2023
Q2 		$2.1K Sell
10
-95
-90% -$18.9K ﹤0.01% 1137
2023
Q1 		$21.2K Buy
105
+18
+21% +$4.08K ﹤0.01% 846
2022
Q4 		$19K Buy
87
+10
+13% +$2.18K ﹤0.01% 808
2022
Q3 		$15K Hold
77
– – ﹤0.01% 816
2022
Q2 		$16K Hold
77
– – ﹤0.01% 843
2022
Q1 		$22K Hold
77
– – ﹤0.01% 841
2021
Q4 		$29K Hold
77
– – ﹤0.01% 742
2021
Q3 		$32K Buy
+77
New +$32K ﹤0.01% 685

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Clearstead Advisors's CRL Position: Q2 2026 in Review

Clearstead Advisors increased its Charles River Laboratories (CRL) stake by 545% in Q2 2026, buying an estimated $21.4K and bringing the position to 142 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Clearstead Advisors first reported a position in CRL in Q3 2021 and has held it in 20 quarters since. The position peaked at $244K in Q2 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Clearstead Advisors held 142 shares of Charles River Laboratories worth $32.2K as of Q2 2026.
  • Clearstead Advisors bought 120 Charles River Laboratories shares in Q2 2026, an estimated $21.4K.
  • Charles River Laboratories made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1640 holding.
  • Clearstead Advisors first reported a position in Charles River Laboratories in Q3 2021 and has held it in 20 quarters since.
  • Clearstead Advisors's Charles River Laboratories position peaked at $244K in Q2 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.